Comment from Vasculitis Foundation Canada

Summary: Jon Stewart, President of the Vasculitis Foundation Canada, opposes the proposed withdrawal of Avacopan for GPA and MPA vasculitis. The organization argues that Avacopan is a significant advancement in treatment that reduces reliance on toxic glucocorticoids and highlights positive real-world evidence of its efficacy.